2015年3期
刊物介紹
本刊主要是及時報道我國在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預(yù)防、臨床治療研究方面的新進(jìn)展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學(xué)，實驗?zāi)[瘤學(xué)、腫瘤細(xì)胞分子生物學(xué)，腫瘤病理學(xué)以及腫瘤影像診斷、腫瘤外科治療、化學(xué)治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學(xué)科，旨在促進(jìn)國內(nèi)外學(xué)術(shù)交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
- Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment
- Prediction of radiosensitivity in primary central nervous system germ cell tumors using dynamic contrast-enhanced magnetic resonance imaging
- microRNA-218 suppresses the proliferation， invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1
- Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China
- microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression
- Comparison of the clinical characteristics and survival between Uyghur patients with hepatitis virus-related and non-B， non-C hepatocellular carcinoma in Xinjiang， China
- Presentation delay in breast cancer patients and its association with sociodemographic factors in North Pakistan
- Epidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patients
- Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer （NSCLC）
- Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma
- Phase I dose-finding study of sorafenib with FOLFOX4 as firstline treatment in patients with unresectable locally advanced or metastatic gastric cancer
- Phase I dose-finding study of sorafenib with FOLFOX4 as firstline treatment in patients with unresectable locally advanced or metastatic gastric cancer